Evidence map›Paper›PMID 25722412›Full record

ArticleScience (New York, N.Y.)2015

Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Yasuteru Sakurai, Andrey A Kolokoltsov, Cheng-Chang Chen, Michael W Tidwell, William E Bauta, Norbert Klugbauer, Christian Grimm, Christian Wahl-Schott, Martin Biel, Robert A Davey

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
327citing papers in PubMed, 2 pooled it
46.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

327 citing papers in PubMed, 2 syntheses or guidelines pooled it, 545 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Allosteric switching of CaThe EMBO journal · 2026
    Article
  8. Ion transport as a determinant of membrane fusion and fission.Nature structural & molecular biology · 2026
    Review
  9. TPC1-dependent control of endosomal pH and transferrin uptake determines cellular iron status.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Endosomal TPC1-mediated CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

267 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Yasuteru SakuraiTexas Biomedical Research Institute, San Antonio, TX, USA.
Andrey A KolokoltsovThe University of Texas Medical Branch, Galveston, TX, USA.
Cheng-Chang ChenCenter for Integrated Protein Science Munich (CIPSM) at the Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Michael W TidwellSouthwest Research Institute, San Antonio, TX, USA.
William E BautaSouthwest Research Institute, San Antonio, TX, USA.
Norbert KlugbauerInstitute for Experimental and Clinical Pharmacology and Toxicology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Christian GrimmCenter for Integrated Protein Science Munich (CIPSM) at the Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Christian Wahl-SchottCenter for Integrated Protein Science Munich (CIPSM) at the Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Martin BielCenter for Integrated Protein Science Munich (CIPSM) at the Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Robert A DaveyTexas Biomedical Research Institute, San Antonio, TX, USA. rdavey@txbiomed.org.
Ludwig-Maximilians-Universität München · DESouthwest Research Institute · USTexas Biomedical Research Institute · USCenter for Integrated Protein Science Munich · DEThe University of Texas Medical Branch at Galveston · USUniversity of Freiburg · DE

Funding

Receptor Trafficking in Entry of Murine Leukemia VirusesR01AI063513 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI DAVEY, ROBERT A · 2006 to 2011
$1.5M
NIAID NIH HHS R01 AI063513NIAID NIH HHS R01AI063513
6 · The paper itself

Abstract

Ebola virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently approved therapy. Cells take up Ebola virus by macropinocytosis, followed by trafficking through endosomal vesicles. However, few factors controlling endosomal virus movement are known. Here we find that Ebola virus entry into host cells requires the endosomal calcium channels called two-pore channels (TPCs). Disrupting TPC function by gene knockout, small interfering RNAs, or small-molecule inhibitors halted virus trafficking and prevented infection. Tetrandrine, the most potent small molecule that we tested, inhibited infection of human macrophages, the primary target of Ebola virus in vivo, and also showed therapeutic efficacy in mice. Therefore, TPC proteins play a key role in Ebola virus infection and may be effective targets for antiviral therapy.

Indexed as

Molecular Targeted TherapyAnimalsAntiviral AgentsBALB 3T3 CellsBenzylisoquinolinesCalcium Channel BlockersCalcium ChannelsEbolavirusFemaleGene Knockout TechniquesHeLa CellsHemorrhagic Fever, EbolaHumansMacrophagesMiceNADPAntiviral AgentsBenzylisoquinolinesCalcium Channel BlockersCalcium ChannelsNAADPNADPtetrandrineTPCN1 protein, humanTPCN1 protein, mouseTPCN2 protein, humanTPCN2 protein, mouseTwo-Pore ChannelsVerapamil

Identifiers

PMID25722412
PMCPMC4550587
OpenAlexW2043620814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.